August 24, 2018
Division of Dockets Management
Food and Drug Administration
Department of Health and Human Services
5630 Fishers Lane, Room 1061
Rockville, MD 20852
Filed electronically at Federal eRulemaking Portal:http://www.regulations.gov:
RE: FDA-2018-N-238; The Food and Drug Administration’s Comprehensive, Multi-Year Nutrition Innovation Strategy; Public Meeting; Request for Comments
Dear Sir or Madame:
The Salt Institute respectfully submits the following comments on the request for comments in the above-referenced docket.
During the last 10 years, the preponderance of peer-reviewed medical evidence has made it abundantly clear that the current levels of sodium intake in USA is within the healthy zone of 2,800 – 5,000mg per day. This was just reconfirmed in a large study published in Lancet using a cohort of 95.767 participants in 369 communities (1). The study’s findings suggested that there may be increased risks to health for consumption levels outside that healthy range. Part of the FDA’s Nutrition Innovation Strategy (https://bit.ly/2MvtgeU) incorrectly states that “Reducing sodium in the diet is the single most effective public health action related to nutrition.” This statement does not correspond to the preponderance of recent evidence and all FDA efforts directed at reducing the current levels of sodium in foods should be halted if the Nutrition Innovation Strategy is to serve the best health interests of American consumers.
The Salt Institute
Reference; (1) Mente A, O’Donnell M, Rangarajan S, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018 Aug 11;392(10146):496-506.